Dr Reddys Laboratories (RDY) EBITDA (2009 - 2026)
Dr Reddys Laboratories' EBITDA came in at $96.71 million for the quarter ended Jun 30, 2026, down 62.8% from $259.87 million a year earlier and down 98.4% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Dr Reddys Laboratories reported EBITDA of $11.7 billion; for the year ended Mar 31, 2026, it was $759 million, down 27.7% from the prior year.
- EBITDA carries a five-year compound annual growth rate of 8.4% (years ended Mar 2021 to Mar 2026).
- Going back by year, EBITDA was $1.05 billion in the year ended Mar 31, 2025 (+6.0%), $991 million in the year ended Mar 31, 2024 (+16.7%), $849 million in the year ended Mar 31, 2023 (+55.8%) and $545 million in the year ended Mar 31, 2022 (+7.5%).
- The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly EBITDA since the quarter ended Mar 31, 2025.
- Year-over-year, EBITDA increased in three of the last six quarters, with growth averaging 71.4%.
- The fastest year-over-year change in EBITDA over five years came in the quarter ended Dec 31, 2024 (growth of 479.2%), and the weakest in the quarter ended Mar 31, 2024 (a decline of 80.7%).
- Business Quant data shows RDY's EBITDA at $5.87 billion (quarter ended Mar 31, 2026), $5.47 billion (quarter ended Dec 31, 2025) and $258.59 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Dr Reddys Laboratories | 10.44 Bn | 9.62 Bn | 396.53 Mn | 96.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 96.71 Mn |
| Mar 31, 2026 | 5.87 Bn |
| Dec 31, 2025 | 5.47 Bn |
| Sep 30, 2025 | 258.59 Mn |
| Jun 30, 2025 | 259.87 Mn |
| Mar 31, 2025 | 55.10 Mn |
| Dec 31, 2024 | 277.55 Mn |
| Sep 30, 2024 | 256.90 Mn |
| Jun 30, 2024 | 260.55 Mn |
| Mar 31, 2024 | 48.42 Mn |
| Dec 31, 2023 | 47.92 Mn |
| Sep 30, 2023 | 261.97 Mn |
| Jun 30, 2023 | 258.44 Mn |
| Mar 31, 2023 | 250.79 Mn |
| Dec 31, 2022 | 190.84 Mn |
| Sep 30, 2022 | 239.21 Mn |
| Jun 30, 2022 | 197.92 Mn |
| Mar 31, 2022 | 59.54 Mn |
| Dec 31, 2021 | 114.72 Mn |
| Sep 30, 2021 | 162.29 Mn |
API Access
Dr Reddys Laboratories EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();